Analyst Ratings for Gilead Sciences (GILD)
GILD Rating Summary
GILD Price Target Summary
- Highest: $177.00 (Scotiabank)
- Lowest: $118.00 (RBC Capital)
- Average: $155.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$155.33 (+7.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$155.33 (+7.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/19/2026 | Barclays | Carter Gould | New Coverage | Equalweight (N/A) |
155.00 (N/A) |
152.74 (143.93) |
-5.77% | Details |
| 1/7/2026 | UBS » Updated 2/25/2026 |
Michael Yee | New Coverage | Buy (Neutral) |
175.00 (175.00) |
118.30 (143.93) |
21.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
